Uses and Limitations of Growth Factors in Renal Failure

Felig P. , Marliss E.B. , Cahill G.F. Jr. Metabolic response to human growth hormone during prolonged starvation. J Clin Invest 1971; 50: 411–21.

Wilmore D.W. , Moylan J.A. , Bristow B.F. , Mason A.D. Jr. , Pruitt B.A. Jr. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 1974; 138: 875–84.

Ponting G.A. , Halliday D. , Teale J.D. , Sim A.J.W. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988; i: 438–40.

Jiang Z-M , He G-Z , Zhang S.Y. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 210: 513–25.

Wilmore D.W. Catabolic illness. Strategies for enhancing recovery. N Engl J Med 1991; 325: 695–702.

Hokken-Koelega A.C.S. , Stijnen T. , de Muinck Keizer-Schrama SMPF Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991; 338: 585–90.

Fine R.N. , Kohaut E.C. , Brown D. , Perlman A.J. Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994; 124: 374–82.

Broyer M. , Guest G. , Crosnier H. , Berard E. Recombinant growth hormone in children after renal transplantation. Lancet 1994; 343: 539–40.

Zeigler T.R. , Lazarus J.M. , Young L.S. , Hakim R.M. , Wilmore D.W. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991; 2: 1130–5.

Schulman G. , Wingard R.L. , Hutchison R.L. , Lawrence P. , Hakim R.M. The effects of recombinant human growth hormone and intra dialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993; 21: 527–34.

Kopple J.D. The rationale for the use of growth hormone or insulin-like growth factor 1 in adult patients with renal failure. Miner Electrolyte Metab 1992; 18: 269–75.

Ikizler T.A. , Wingard R.L. , Breyer J.A. , Schulman G. , Parker R.A. , Hakim R.M. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994; 46: 1178–83.

Holliday M.A. Calorie deficiency in children with uremia: Effect upon growth. Pediatrics 1972; 50: 590–7.

Arnold W.C. , Danford D. , Holliday M.A. Effects of caloric supplementation on growth in children with uremia. Kidney Int 1983; 24: 205–9.

Albitol C.L. , Warady B.A. , Massie M.D. Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: A report of the growth failure in children with renal disease study. J Pediatr 1990; 116: S46–54.

Wühl E. , Haffner D. , Tönshoff B. , Mehls O. and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Kidney Int 1993; 44(Suppl 43): S76–82.

Tönshoff B. , Haffner D. , Mehls O. Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience. Kidney Int 1993; 44: 199–207.

Hokken-Koelega A.C.S. , Hackeng W.H.L. , Stijnen T. , Wit J.M. , de Muinck Keizer-Schrama SMPF , Drop S.L.S. Twenty-four hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-1 and factor-II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J Clin Endocrinol Metab 1990; 71: 688–95.

Rodger R.S.C. , Dewar J.H. , Turner S.J. , Watson M.J. , Ward M.K. Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis. Nephron 1986; 43: 169–72.

Bessarione D. , Perfumo F. , Giusti M. Growth hormone response to growth hormone-releasing hormone in normal and uraemic children. Comparison with hypoglycaemia following insulin administration. Acta Endocrinol (Copenh) 1987; 114: 5–11.

Allegra V. , Amendolagine F. , Mengozzi G. , Tenti M. , Vasile A. Growth hormone secretion abnormalities in uremic patients: Which is the role of impaired glucose hypothalamic sensitivity? Nephron 1988; 48: 76–7.

Clemmons D.R. , Underwood L.E. Nutritional regulation of IGF-l and IGF binding proteins. Annu Rev Nutr 1991; 11: 393–412.

Belcher HJCR , Mercer D. , Judkins K.C. Biosynthetic human growth hormone in burned patients: A pilot study. Burns 1989; 15: 99–107.

Dahn M.S. , Lange P. , Jacobs L.A. Insulin-like growth factor-l production is inhibited in human sepsis. Arch Burg 1988; 123: 1409–14.

Shahmir E. , Peng S. , Fouque D. , Kopple J.D. Effect of insulin-like growth factor-l (IGF-l) on nitrogen balance in malnourished CAPD patients. J Am Boc Nephrol 1995; 6: 587.

Bennington J.L. , Strathearn M.D. , Williams R.D. , Spencer E.M. Autocrine stimulation by IGF -1 of renal cell carcinoma growth in vitro. In: Spencer E.M. , ed. Modern concepts of insulin-like growth factors. Amsterdam: Elsevier Science Publishers, 1991: 567–71.

Kopple J.D. , Massry S.G. Is there an association between neoplasia and primary or secondary hyperparathyroidism? Am J Nephrol 1988; 8: 437–48.